CareLit Fachartikel

Immune correlates against SARS-CoV-2 infection – results of population and hospital-based studies in the IMMUNEBRIDGE project in Germany, 2022

Manuela, H.S.; Lange, B.; Dreier, M.; Jäger, V.; Karch, A.; Rücker, V.; Streeck, H.; Blaschke, S.; Pestersmann, A.; Toepfner, N.; Nauck, M.; Vonholt, I.; Budde, A.; Bartz, A.; Kurosins, M.; Berner, R.; Borsche, M.; Brandhorst, G.; Brinkmann, M.; Budde, K.; De… · Das Gesundheitswesen · 2023 · Heft 8/09 · S. 1 bis 1

Dokument
577720
CareLit-ID
Jahr
2023
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Das Gesundheitswesen
Autor:innen
Manuela, H.S.; Lange, B.; Dreier, M.; Jäger, V.; Karch, A.; Rücker, V.; Streeck, H.; Blaschke, S.; Pestersmann, A.; Toepfner, N.; Nauck, M.; Vonholt, I.; Budde, A.; Bartz, A.; Kurosins, M.; Berner, R.; Borsche, M.; Brandhorst, G.; Brinkmann, M.; Budde, K.; De…
Ausgabe
Heft 8/09 / 2023
Jahrgang 85
Seiten
1 bis 1
Erschienen: 2023-08-22 13:00:00
ISSN
0941-3790
DOI
10.1055/s-0043-1770410

Zusammenfassung

Einleitung In spring 2022, Germany lacked systematically collected population-based SARS-CoV-2 data allowing real-time assessment of protection levels against severe course of COVID-19. To fill this gap, the IMMUNEBRIDGE project, a joint collaboration of eight populationand one hospital-based studies, was launched. Methoden We resampled and collected data on SARS-CoV-2 in the general German population including children between June and November 2022. Built on literature synthesis, we formed four protection levels against severe COVID-19 based on the number of self-reported infections/vaccinations and nucleocaps…

Schlagworte

SARS-CoV-2 COVID-19 Immunität Antikörper Bevölkerung Studien Schutzlevel IMMUNEBRIDGE Immunity Antibodies Population Epidemiology Das Gesundheitswesen